RE-CIRCUIT study-randomized evaluation of dabigatran etexilate compared to warfarin in pulmonary vein ablation: Assessment of an uninterrupted periprocedural anticoagulation strategy

Hugh Calkins; Edward P. Gerstenfeld; Richard Schilling; Atul Verma; Stephan Willems

doi:10.1016/j.amjcard.2014.10.002

RE-CIRCUIT study-randomized evaluation of dabigatran etexilate compared to warfarin in pulmonary vein ablation: Assessment of an uninterrupted periprocedural anticoagulation strategy

Hugh Calkins, Edward P. Gerstenfeld, Richard Schilling, Atul Verma, Stephan Willems

School of Medicine

Research output: Contribution to journal › Letter › peer-review

30 Scopus citations

Original language	English (US)
Pages (from-to)	154-155
Number of pages	2
Journal	American Journal of Cardiology
Volume	115
Issue number	1
DOIs	https://doi.org/10.1016/j.amjcard.2014.10.002
State	Published - Jan 1 2015

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.amjcard.2014.10.002

Cite this

RE-CIRCUIT study-randomized evaluation of dabigatran etexilate compared to warfarin in pulmonary vein ablation: Assessment of an uninterrupted periprocedural anticoagulation strategy. / Calkins, Hugh; Gerstenfeld, Edward P.; Schilling, Richard et al.
In: American Journal of Cardiology, Vol. 115, No. 1, 01.01.2015, p. 154-155.

Research output: Contribution to journal › Letter › peer-review

@article{80bc89517fa4499e91089b938f01cfb8,

title = "RE-CIRCUIT study-randomized evaluation of dabigatran etexilate compared to warfarin in pulmonary vein ablation: Assessment of an uninterrupted periprocedural anticoagulation strategy",

author = "Hugh Calkins and Gerstenfeld, {Edward P.} and Richard Schilling and Atul Verma and Stephan Willems",

note = "Funding Information: The RE-CIRCUIT study (Randomized Evaluation of dabigatran etexilate Compared to warfarIn in pulmonaRy vein ablation: assessment of an uninterrupted peri-proCedUral antIcoagulation sTrategy) is funded by Boehringer Ingelheim . ",

year = "2015",

month = jan,

day = "1",

doi = "10.1016/j.amjcard.2014.10.002",

language = "English (US)",

volume = "115",

pages = "154--155",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - RE-CIRCUIT study-randomized evaluation of dabigatran etexilate compared to warfarin in pulmonary vein ablation

T2 - Assessment of an uninterrupted periprocedural anticoagulation strategy

AU - Calkins, Hugh

AU - Gerstenfeld, Edward P.

AU - Schilling, Richard

AU - Verma, Atul

AU - Willems, Stephan

N1 - Funding Information: The RE-CIRCUIT study (Randomized Evaluation of dabigatran etexilate Compared to warfarIn in pulmonaRy vein ablation: assessment of an uninterrupted peri-proCedUral antIcoagulation sTrategy) is funded by Boehringer Ingelheim .

PY - 2015/1/1

Y1 - 2015/1/1

UR - http://www.scopus.com/inward/record.url?scp=84915747517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84915747517&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2014.10.002

DO - 10.1016/j.amjcard.2014.10.002

M3 - Letter

C2 - 25456859

AN - SCOPUS:84915747517

SN - 0002-9149

VL - 115

SP - 154

EP - 155

JO - American Journal of Cardiology

JF - American Journal of Cardiology

IS - 1

ER -

RE-CIRCUIT study-randomized evaluation of dabigatran etexilate compared to warfarin in pulmonary vein ablation: Assessment of an uninterrupted periprocedural anticoagulation strategy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this